Overview

Gender

male

Investor Type

Investment Partner

Dr. Wallnöfer joined BioMedPartners as a new Partner in 2016.

Dr. Wallnöfer is a senior executive leader with more than 20 years experience in the pharmaceutical industry, including 12 years as a member of the F. Hoffmann-La Roche Pharma R&D Leadership and Portfolio Committee. He led the Roche Pharma Cardiovascular & Metabolism Disease Area and left Roche in 2015 after the company strategically decided to exit these reasearch areas.

At Roche he was involved in several successful product development programs. As Head of Clinical Research & Exploratory Development he and his groups were involved in the Due Diligence evaluations for in-licensing projects and product acquisitions.
Dr. Wallnöfer had also a key role in the integration of the Roche and Genentech Development organizations and led subsequently Early Development and Portfolio Management at Roche. He will strengthen BioMed expertise in Pharma from discovery to regulatory filing submissions.

Dr. Wallnöfer has a PhD in pharmacology from the University of Basel and trained as a fellow in Clinical Pharmacology at the University of Leiden, the Netherlands. He holds a Master of Technology Enterprise and an Executive MBA from IMD Lausanne.